Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study

Plain-language summary

This study uses biospecimens and data to examine the molecular and clinical features of bone marrow failure syndromes. It includes participants aged 2 and older with bone marrow failure, along with age-matched healthy volunteers. It is a study without an assigned phase and enrolls participants by invitation.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Enrolling by invitation

Sponsor

National Heart, Lung, and Blood Institute (NHLBI)

Start date

9/9/2025

Estimated completion

7/11/2030

Countries

United States

Related genes

Locations

• Bethesda, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

* This study will utilize biospecimens and data with identifiers from up to 1,400 research participants with BMFS, aged 2 years and older, alongside age matched healthy volunteers aged 8 years and older.